UB Study Shows Obesity Puts People At Risk For Early Death

May 30, 1996

This article will be published in the September issue of Molecular Psychiatry, a peer-reviewed journal published by Stockton Press/Macmillan Press.

GENETIC VARIANTS OF THE HUMAN OBESITY (OB) GENE:
ASSOCIATION WITH BODY MASS INDEX IN YOUNG WOMEN, PSYCHIATRIC SYMPTOMS, AND INTERACTION WITH THE DOPAMINE D2 RECEPTOR (DRD2) GENE
EMBARGOED UNTIL SEPTEMBER 15, 1996 -- In a study reported in the current issue of the journal Molecular Psychiatry, researchers at City of Hope National Medical Center, Duarte, California, USA and Loma Linda University, Loma Linda, California, USA examined a complex, genetically variable region (polymorphism) close to the human obesity (OB) gene and found that certain genetic variants next to the human OB gene are associated with obesity in young women, but not young men. They also found that the genetic variants at the OB gene were also associated in these women with depression and anxiety, two of the behaviors most often associated with obesity. The results suggest the depression was a direct result of the OB gene variants and not just secondary to the obesity.

The cloning and sequencing of the mouse and the human obesity (OB) genes have been greeted with enormous excitement. When mice have a defective OB gene on both chromosomes, they are very obese and treatment with leptin, the product of the OB gene, causes rapid weight loss. This led to the hope that obese humans also had a defective OB gene, and treatment with leptin would also cause weight loss. However, many subsequent studies have shown that obese humans have too much leptin, not too little, and no mutations of the OB gene itself were found. Thus, the OB gene - leptin story is far more complex than originally thought.

In 1993 DE Comings and colleagues found that variants of the dopamine D2 receptor gene (DRD2), originally reported by K Blum and EP Noble as being associated with severe alcoholism, were also associated with obesity. Blum and Noble confirmed this association, and both groups found an association between the DRD2 gene and drug addiction. All three of these substances (alcohol, drugs and food), stimulate the reward pathways of the brain. Now Comings and coworkers found that the OB and DRD2 genes were additive in their effect on obesity in young women. Both genes combined accounted for 22% of the obesity in young women.

These results are consistent with obesity being the result of many different genes (polygenic), with a greater involvement of genetic factors in women and younger subjects, and suggest that variants of the OB gene are causally involved not only with human obesity but with its associated behavioral disorders. An independent commentary by Dr. Gerald J. LaHoste (University of California at Irvine, USA; FAX: + 1 714 824-2447; phone: +1 714 824-4722; e-mail: glahoste@parker.bio.uci.edu) also appears in the current issue of Molecular Psychiatry.

Authors: DE Comings, R Gade, J MacMurray, D Muhleman, P Johnson, R Verde, WR Peters. City of Hope National Medical Center, Duarte, California, USA and Loma Linda University, Loma Linda, California, USA Molecular Psychiatry 1996; vol. 1, issue 4 (September 1996).
***For information on the scientific aspects of the article please contact the author: Dr. David E. Comings, Department of Medical Genetics,
City of Hope National Medical Center,
1500 East Duarte Road, Duarte, CA 91010-0269, USA
phone: +1 (818) 359-8111; FAX: +1 (818) 301-8980

Editor: Julio Licinio, MD
Editorial assistant: Rachel Lisman
NIH, Bldg. 10/2D46, 10 Center Drive, Bethesda, MD 20892-1284, USA
phone: (301) 496-6885; FAX: +1 (301) 402-1561; e-mail: licinio@nih.gov

Publisher: Marija Vukovojac, phone and FAX: +44 1483 892119
e-mail: 100743.2265@Co mpuServe.COM

University at Buffalo

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.